Study shows increased immunogenicity of extended mRNA SARS-CoV-2 vaccine dosing intervals.
7 Dec, 2021 | 10:21h | UTCImmunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals – JAMA
Commentary on Twitter (thread – click for more)
1/ Not surprisingly, a longer delay between 1st & 2nd doses of mRNA COVID vaccines (i.e. 6-7 weeks rather than 3-4 weeks) results in better immune responses.https://t.co/XhiU6u0hYb
— Céline Gounder, MD, ScM, FIDSA (@celinegounder) December 3, 2021